BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 16488363)

  • 1. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene.
    Sosnay PR; Siklosi KR; Van Goor F; Kaniecki K; Yu H; Sharma N; Ramalho AS; Amaral MD; Dorfman R; Zielenski J; Masica DL; Karchin R; Millen L; Thomas PJ; Patrinos GP; Corey M; Lewis MH; Rommens JM; Castellani C; Penland CM; Cutting GR
    Nat Genet; 2013 Oct; 45(10):1160-7. PubMed ID: 23974870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of CFTR mutations in the Czech population: positive impact of integrated clinical and laboratory expertise, detection of novel/de novo alleles and relevance for related/derived populations.
    Křenková P; Piskáčková T; Holubová A; Balaščaková M; Krulišová V; Čamajová J; Turnovec M; Libik M; Norambuena P; Štambergová A; Dvořáková L; Skalická V; Bartošová J; Kučerová T; Fila L; Zemková D; Vávrová V; Koudová M; Macek M; Krebsová A; Macek M
    J Cyst Fibros; 2013 Sep; 12(5):532-7. PubMed ID: 23276700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation nomenclature in practice: findings and recommendations from the cystic fibrosis external quality assessment scheme.
    Berwouts S; Morris MA; Girodon E; Schwarz M; Stuhrmann M; Dequeker E
    Hum Mutat; 2011 Nov; 32(11):1197-203. PubMed ID: 21796730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients.
    Green DM; McDougal KE; Blackman SM; Sosnay PR; Henderson LB; Naughton KM; Collaco JM; Cutting GR
    Respir Res; 2010 Oct; 11(1):140. PubMed ID: 20932301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex ligation-dependent probe amplification identification of whole exon and single nucleotide deletions in the CFTR gene of Hispanic individuals with cystic fibrosis.
    Schrijver I; Rappahahn K; Pique L; Kharrazi M; Wong LJ
    J Mol Diagn; 2008 Jul; 10(4):368-75. PubMed ID: 18556774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CFTR mutations in Turkish and North African cystic fibrosis patients in Europe: implications for screening.
    Lakeman P; Gille JJ; Dankert-Roelse JE; Heijerman HG; Munck A; Iron A; Grasemann H; Schuster A; Cornel MC; Ten Kate LP
    Genet Test; 2008 Mar; 12(1):25-35. PubMed ID: 18373402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of the basic defect of homozygous CFTR mutation genotypes in humans.
    Stanke F; Ballmann M; Bronsveld I; Dörk T; Gallati S; Laabs U; Derichs N; Ritzka M; Posselt HG; Harms HK; Griese M; Blau H; Mastella G; Bijman J; Veeze H; Tümmler B
    J Med Genet; 2008 Jan; 45(1):47-54. PubMed ID: 18178635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of mutations in the CFTR gene in cystic fibrosis patients of Spanish ancestry.
    Alonso MJ; Heine-Suñer D; Calvo M; Rosell J; Giménez J; Ramos MD; Telleria JJ; Palacio A; Estivill X; Casals T
    Ann Hum Genet; 2007 Mar; 71(Pt 2):194-201. PubMed ID: 17331079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CFTR gene analysis in Latin American CF patients: heterogeneous origin and distribution of mutations across the continent.
    Pérez MM; Luna MC; Pivetta OH; Keyeux G
    J Cyst Fibros; 2007 May; 6(3):194-208. PubMed ID: 16963320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens.
    Dörk T; Dworniczak B; Aulehla-Scholz C; Wieczorek D; Böhm I; Mayerova A; Seydewitz HH; Nieschlag E; Meschede D; Horst J; Pander HJ; Sperling H; Ratjen F; Passarge E; Schmidtke J; Stuhrmann M
    Hum Genet; 1997 Sep; 100(3-4):365-77. PubMed ID: 9272157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cystic fibrosis-associated mutations in the fourth intracellular loop of cystic fibrosis transmembrane conductance regulator.
    Cotten JF; Ostedgaard LS; Carson MR; Welsh MJ
    J Biol Chem; 1996 Aug; 271(35):21279-84. PubMed ID: 8702904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-associated mutations in the fourth cytoplasmic loop of cystic fibrosis transmembrane conductance regulator compromise biosynthetic processing and chloride channel activity.
    Seibert FS; Linsdell P; Loo TW; Hanrahan JW; Clarke DM; Riordan JR
    J Biol Chem; 1996 Jun; 271(25):15139-45. PubMed ID: 8662892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of eight novel mutations in a collaborative analysis of a part of the second transmembrane domain of the CFTR gene.
    Mercier B; Lissens W; Novelli G; Kalaydjieva L; De Arce M; Kapranov N; Klain NC; Lenoir G; Chauveau P; Lenaerts C
    Genomics; 1993 Apr; 16(1):296-7. PubMed ID: 7683628
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeted mutation screening panels expose systematic population bias in detection of cystic fibrosis risk.
    Lim RM; Silver AJ; Silver MJ; Borroto C; Spurrier B; Petrossian TC; Larson JL; Silver LM
    Genet Med; 2016 Feb; 18(2):174-9. PubMed ID: 25880441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Just breathe: a review of sex and gender in chronic lung disease.
    Somayaji R; Chalmers JD
    Eur Respir Rev; 2022 Mar; 31(163):. PubMed ID: 35022256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed cystic fibrosis presentation in children in the absence of newborn screening.
    Jackson A; Foley L; Daly L; Fitzpatrick P; Harrington M; Zhou S; Kelleher C
    Ir Med J; 2010 Apr; 103(4):113-6. PubMed ID: 20486315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis.
    Nick JA; Chacon CS; Brayshaw SJ; Jones MC; Barboa CM; St Clair CG; Young RL; Nichols DP; Janssen JS; Huitt GA; Iseman MD; Daley CL; Taylor-Cousar JL; Accurso FJ; Saavedra MT; Sontag MK
    Am J Respir Crit Care Med; 2010 Sep; 182(5):614-26. PubMed ID: 20448091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed diagnosis of females with respiratory presentation of cystic fibrosis did not segregate with poorer clinical outcome.
    McCormick J; Sims EJ; Mehta A
    J Clin Epidemiol; 2006 Mar; 59(3):315-22. PubMed ID: 16488363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: evidence from the United States Cystic Fibrosis Foundation registry data.
    Lai HJ; Cheng Y; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S57-63. PubMed ID: 16202784
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.